Your fear is 100% dependent on you for its survival.”
- Steve Maraboli
Today, we look at a small developmental concern that has not has a lot of news flow in recent months and whose stock is down some 40% from recent highs. However, several key readouts through year end could change sentiment on the shares. Our in-depth look at this name follows below.
Company Overview
KalVista Pharmaceuticals, Inc. (KALV) is a Cambridge, Massachusetts-based, clinical-stage biopharmaceutical company focused on the development of small molecule protease inhibitors for diseases with significant unmet need.